Financials Nova Leap Health Corp.

Equities

NLH

CA66980G1090

Healthcare Facilities & Services

Market Closed - Toronto S.E. 12:15:15 2024-07-12 pm EDT 5-day change 1st Jan Change
0.28 CAD 0.00% Intraday chart for Nova Leap Health Corp. +3.70% -6.67%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 13.97 20.1 38.63 38.26 15.89 19.51
Enterprise Value (EV) 1 17.31 24.17 41.82 42.72 18.59 20.01
P/E ratio -11.8 x -18.8 x 30.5 x 24.1 x -18 x -18.5 x
Yield - - - - - -
Capitalization / Revenue 1.35 x 1.15 x 2.23 x 1.8 x 0.56 x 0.75 x
EV / Revenue 1.67 x 1.39 x 2.42 x 2.01 x 0.66 x 0.76 x
EV / EBITDA -53.9 x 61.5 x 2,714 x -75.7 x -272 x 20.1 x
EV / FCF -16.5 x 36.5 x 53.7 x -24.1 x 11.6 x 10.3 x
FCF Yield -6.05% 2.74% 1.86% -4.16% 8.62% 9.73%
Price to Book 2.07 x 2.86 x 3.93 x 2.07 x 0.85 x 1.07 x
Nbr of stocks (in thousands) 59,640 61,464 65,612 79,295 86,209 86,209
Reference price 2 0.2343 0.3270 0.5888 0.4824 0.1844 0.2263
Announcement Date 3/14/19 3/12/20 3/11/21 3/10/22 3/8/23 3/7/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 10.36 17.4 17.31 21.28 28.21 26.18
EBITDA 1 -0.321 0.3927 0.0154 -0.564 -0.0683 0.9945
EBIT 1 -0.7637 -0.1128 -0.3961 -1.231 -1.062 0.4602
Operating Margin -7.37% -0.65% -2.29% -5.79% -3.77% 1.76%
Earnings before Tax (EBT) 1 -1.041 -0.9511 0.1255 2.473 -1.207 -1.366
Net income 1 -0.9613 -1.056 1.256 1.761 -0.8357 -1.055
Net margin -9.28% -6.07% 7.26% 8.27% -2.96% -4.03%
EPS 2 -0.0198 -0.0173 0.0193 0.0200 -0.0103 -0.0122
Free Cash Flow 1 -1.048 0.6625 0.778 -1.776 1.602 1.946
FCF margin -10.11% 3.81% 4.49% -8.34% 5.68% 7.43%
FCF Conversion (EBITDA) - 168.69% 5,049.24% - - 195.72%
FCF Conversion (Net income) - - 61.93% - - -
Dividend per Share - - - - - -
Announcement Date 3/14/19 3/12/20 3/11/21 3/10/22 3/8/23 3/7/24
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 5.91 7.297 6.987 7.142 6.78 6.396 6.677 6.554 6.552 6.43
EBITDA 1 -0.0589 0.2276 0.034 0.3255 0.0713 0.086 0.3861 0.4342 0.5713 0.3618
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 3/10/22 5/12/22 8/12/22 11/10/22 3/8/23 5/11/23 8/10/23 11/9/23 3/7/24 5/9/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3.34 4.08 3.18 4.47 2.69 0.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -10.4 x 10.38 x 206.5 x -7.919 x -39.44 x 0.5065 x
Free Cash Flow 1 -1.05 0.66 0.78 -1.78 1.6 1.95
ROE (net income / shareholders' equity) -22.4% -15.3% 14.9% 12.4% -4.5% -5.72%
ROA (Net income/ Total Assets) -6.21% -0.53% -1.56% -3.47% -2.62% 1.28%
Assets 1 15.48 198.9 -80.32 -50.68 31.93 -82.23
Book Value Per Share 2 0.1100 0.1100 0.1500 0.2300 0.2200 0.2100
Cash Flow per Share 2 0.0200 0.0300 0.0400 0.0200 0.0100 0.0100
Capex 1 0.02 0.02 0.01 - 0.07 0.03
Capex / Sales 0.19% 0.09% 0.04% - 0.25% 0.11%
Announcement Date 3/14/19 3/12/20 3/11/21 3/10/22 3/8/23 3/7/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2056 USD
Average target price
0.44 USD
Spread / Average Target
+113.96%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. NLH Stock
  4. Financials Nova Leap Health Corp.